Bebo Health (XPAR:MLBBO) ROE % Adjusted to Book Value: 0.00% (As of Dec. 2025)

Bebo Health XPAR:MLBBO 47 ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Bebo Health's ROE % for the quarter that ended in Dec. 2025 was 0.35%. Bebo Health's PB Ratio for the quarter that ended in Dec. 2025 was 81.36. Bebo Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 0.00%.

Bebo Health ROE % Adjusted to Book Value Related Terms

Bebo Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Bebo Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bebo Health ROE % Adjusted to Book Value Chart

Bebo Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.00

1.26

0.24

0.26

0.00

Bebo Health Semi-Annual Data
	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			0.00	1.26	0.24	0.26	0.00

XPAR:MLBBO vs CASY, WSM, DKS: ROE % Adjusted to Book Value Comparison

For the Specialty Retail subindustry, Bebo Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bebo Health ROE % Adjusted to Book Value vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bebo Health's ROE % Adjusted to Book Value falls into.

Save Embed

47GF Score

Bebo Health SA XPAR:MLBBO

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bebo Health ROE % Adjusted to Book Value Calculation

Bebo Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.35%	/	81.36
	=	0.00%

Bebo Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.35%	/	81.36
	=	0.00%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 0.00% mean?

Bebo Health (XPAR:MLBBO) has a ROE % Adjusted to Book Value of 0.00% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bebo Health and its competitors.

Is Bebo Health's ROE % Adjusted to Book Value too high?

Bebo Health's current ROE % Adjusted to Book Value is 0.00%. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Bebo Health's ROE % Adjusted to Book Value compare to CASY and WSM?

Bebo Health's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Retail - Cyclical company?

A good ROE % Adjusted to Book Value depends on the Retail - Cyclical industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bebo Health and its competitors. Bebo Health's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bebo Health stock overvalued right now?

Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?

Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued. The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03. GuruFocus considers Bebo Health to be Significantly Overvalued.

Key valuation signals for XPAR:MLBBO:

ROE % Adjusted to Book Value: 0.00%
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.